Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Taking health systems research syntheses to the next level: overviews of systematic reviews.

Ranson, M Kent; Evans, David B.

Cochrane Database Syst Rev ; 9: ED000123, 2017 09 13.

Artículo en Inglés | MEDLINE | ID: mdl-28975617

2.

A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC.

Dean, E J; Ward, T; Pinilla, C; Houghten, R; Welsh, K; Makin, G; Ranson, M; Dive, C.

Br J Cancer ; 102(1): 97-103, 2010 Jan 05.

Artículo en Inglés | MEDLINE | ID: mdl-19904270

3.

Biomarker method validation in anticancer drug development.

Cummings, J; Ward, T H; Greystoke, A; Ranson, M; Dive, C.

Br J Pharmacol ; 153(4): 646-56, 2008 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-17876307

4.

Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.

Ranson, M; Davidson, N; Nicolson, M; Falk, S; Carmichael, J; Lopez, P; Anderson, H; Gustafson, N; Jeynes, A; Gallant, G; Washington, T; Thatcher, N.

J Natl Cancer Inst ; 92(13): 1074-80, 2000 Jul 05.

Artículo en Inglés | MEDLINE | ID: mdl-10880550

5.

Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer.

von Pawel, J; Gatzemeier, U; Pujol, J L; Moreau, L; Bildat, S; Ranson, M; Richardson, G; Steppert, C; Rivière, A; Camlett, I; Lane, S; Ross, G.

J Clin Oncol ; 19(6): 1743-9, 2001 Mar 15.

Artículo en Inglés | MEDLINE | ID: mdl-11251005

6.

Single-agent paclitaxel in advanced non-small cell lung cancer: single-center phase II study using a 3-hour administration schedule.

Ranson, M R; Jayson, G; Perkins, S; Anderson, H; Thatcher, N.

Semin Oncol ; 24(4 Suppl 12): S12-6-S12-9, 1997 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-9331111

7.

Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancer.

Braybrooke, J P; Ranson, M; Manegold, C; Mattson, K; Thatcher, N; Cheverton, P; Sekiguchi, M; Suzuki, M; Oyama, R; Talbot, D C.

Lung Cancer ; 41(2): 215-9, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-12871785

8.

Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008.

Vine, K L; Matesic, L; Locke, J M; Ranson, M; Skropeta, D.

Anticancer Agents Med Chem ; 9(4): 397-414, 2009 May.

Artículo en Inglés | MEDLINE | ID: mdl-19442041

9.

Review of recent trials of chemotherapy for advanced breast cancer: the taxanes.

Clemons, M; Leahy, M; Valle, J; Jayson, G; Ranson, M; Howell, A.

Eur J Cancer ; 33(13): 2183-93, 1997 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-9470804

10.

Management of elderly patients with lung cancer.

Ranson, M R; White, S; Thatcher, N.

Curr Oncol Rep ; 2(1): 90-5, 2000 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-11122829

11.

Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for haematological rescue after high-dose consolidation chemotherapy.

Van Hoef, M E; Baumann, I; Lange, C; Luft, T; de Wynter, E A; Ranson, M; Morgenstern, G R; Yvers, A; Dexter, T M; Testa, N G.

Ann Oncol ; 5(3): 217-24, 1994 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-7514434

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: